Physician

Geoffrey V Martin, MD

According to 2025 Medicare claims, Geoffrey Martin, MD (NPI: 1245675800) practices radiation oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is CHESAPEAKE UROLOGY ASSOCIATES, LLC (NPI: 1700153921; TIN: 522146172) and primary practice location at 20878-1413.

Martin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 313 traditional Medicare patients, billed 12,080 HCPCS/CPT codes, and received $2,224,411 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 183 prescription claims across 62 beneficiaries totaling $74,786 in drug costs, led by Orgovyx (Relugolix). Open Payments data shows 23 records totaling $785. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $39,867 to $2,224,411. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,772 to $74,786. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	96	535	$39,867
2019	219	1,680	$111,345
2020	196	1,662	$110,808
2021	211	1,749	$123,899
2022	85	4,012	$1,010,540
2023	222	6,366	$1,385,352
2024	313	12,080	$2,224,411

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	29	$2,772
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	16	55	$1,427
2019	61	241	$5,639
2020	74	255	$5,067
2021	68	228	$5,156
2022	44	117	$2,772
2023	41	113	$2,676
2024	62	183	$74,786

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	100	2,644	$328
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	153	153	$185
77336	Continuing radiation therapy consultation per week	99	482	$82
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	130	172	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	293	416	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	27	806	$70,146
Solifenacin Succinate	Solifenacin Succinate	17	1,350	$1,446
Tamsulosin Hcl	Tamsulosin Hcl	87	5,940	$1,415
Alfuzosin Hcl Er	Alfuzosin Hcl	14	1,200	$363

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$785	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Geoffrey V. Martin, MD?

Tedicare shows public-source Medicare data for Geoffrey V. Martin, MD (NPI 1245675800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Geoffrey V. Martin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Geoffrey V. Martin, MD?

Geoffrey V. Martin, MD is linked to CHESAPEAKE UROLOGY ASSOCIATES, LLC (billing NPI 1700153921) in the available physician profile data.

Does Geoffrey V. Martin, MD have Open Payments data?

Geoffrey V. Martin, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.